
As we come to the end of the first half of the year, the M&A year to date can be summarized in relatively positive terms. Global deal activity is looking up, with private equity in particular making an astounding comeback. In this mergermarket podcast, brought to you by IntraLinks, contributors analyse the global M&A market, explore the dealmaking landscape to date and provide an outlook for the coming six months.
Contributors:
The 2010 Q2 IntraLinks Deal Flow Indicator reports a 40 percent increase in global M&A deal activity versus Q2 2009. Despite the continuing economic uncertainty, IntraLinks observed an 11 percent increase in global activity when comparing Q2 2010 to Q1 2010. Download the latest Deal Flow Indicator to learn more about observations in deal flow for 2010.
DOWNLOAD
This webcast will provide in house counsel, compliance professionals, and HR with an overview of:
mergermarket, in association with IntraLinks, hosted the live webcast, Intellectual Property M&A. The webcast will discuss some the importance of Intellectual Property as a driver of M&A.
In this latest quarterly podcast, mergermarket and IntraLinks assembled a panel of transatlantic dealmakers to discuss what influenced M&A from April to September. After a bumper first half for global deal volumes, Q3 saw the market hit by a wave of uncertainty over sovereign debt and sluggish global economic growth. But what was our panel’s impression of the market?
Discover how IntraLinks can help Fund Administrators capitalize on emerging opportunities while controlling their costs. The presentation will walk you through the IntraLinks solutions and capabilities Fund Administrators are leveraging to expand their service suite, engage earlier with prospects and attract large self administered funds that are moving to 3rd party administration.
Understand how the use of extended enterprise collaboration technologies is helping the clinical research community gain operational efficiencies and strengthen relationships between clinical research sites and Sponsors/CROs. Hear firsthand how clinical research sites interact, correspond, collaborate and share information with Sponsor Organizations, and their perceived challenges with their current methods.